4-(4-(Dimethylamino)phenylazo)benzoic acid N-succinimidyl ester
CAS : 146998-31-4
Ref. 3D-FD11388
1g | Arrêté | ||
50mg | Arrêté | ||
100mg | Arrêté | ||
250mg | Arrêté | ||
500mg | Arrêté |
Informations sur le produit
- Dabcyl Acid, Se
- Dabcyl, Se
- Dabcyl Succinimide Ester
- Dabcyl-N-Succinimidyl Ester
- Dabcyl-Osu
- Dabcyl-Nhs
- Dabcyl N-Hydroxysuccinimide Ester
- 4-(Dimethylamino)Azobenzene-4'-Carboxylic Acid N-Succinimidyl Ester
- 4-[4-(Dimethylamino)phenylazo]benzoic acid N-succinimidyl ester
- 1-{[(4-{(E)-[4-(dimethylamino)phenyl]diazenyl}phenyl)carbonyl]oxy}pyrrolidine-2,5-dione
- Voir d'autres synonymes
4-(4-dimethylamino)phenylazo)benzoic acid N-succinimidyl ester is a fatty acid that binds to leukocyte antigen. It also has protease activity and is a monoclonal antibody. 4-(4-Dimethylamino)phenylazo)benzoic acid N-succinimidyl ester has been shown to be toxic in animal studies, but the toxicity profiles of this compound have not yet been established in humans. This compound has been shown to inhibit the growth of cancer cells and may be used as an adjuvant therapy for cancer or cancer tissue. The mechanism by which this drug works is proteolytic, meaning it breaks down proteins into smaller peptides.